Hersteller

ViennaLab Diagnostics GmbH

Gaudenzdorfer Guertel 43-45 , 1120 Vienna
Österreich

Telefon +43 1 8120156-0
Fax +43 1 8120156
info@viennalab.com

Dieser Aussteller ist Mitaussteller von
ADVANTAGE AUSTRIA Wirtschaftskammer Österreich

Messehalle

  • Halle 3 / F56
 Interaktiver Hallenplan

Hallenplan

MEDICA 2016 Hallenplan (Halle 3): Stand F56

Geländeplan

MEDICA 2016 Geländeplan: Halle 3

Unser Angebot

Produktkategorien

  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.16  Therapeutische Medikamentenüberwachung
  • 03.02.16.01  Diagnostika / Kits für die Pharmaka-Bestimmung
  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.17  Tumormarker
  • 03.02.17.01  Diagnostika / Kits für die Tumormarker-Bestimmung

Unsere Produkte

Produktkategorie: DNA Diagnose Kits, Gentests / Molekularbiologische Diagnostik, DNA-Analytik

Congenital adrenal hyperplasia (CAH) Assays

Congenital adrenal hyperplasia (CAH) is an inherited disorder of steroid hormone synthesis.

The CAH StripAssay® detects common point mutations, whereas the CAH RealFast™ CNV Assay identifies copy number variations (CNV) in the CYP21A2 gene in patients with congenital adrenal hyperplasia (CAH).

CAH StripAssay®
CAH RealFast™ CNV Assay

Mehr Weniger

Produktkategorie: DNA Diagnose Kits, Gentests / Molekularbiologische Diagnostik, DNA-Analytik

CF StripAssays®

Cystic Fibrosis (CF) is the most common life-limiting autosomal recessive disorder in the Caucasian population.
ViennaLab offers population-tailored CF StripAssays® including 46 common CFTR mutations and the polyT variant 5T/7T/9T in intron 8.

CF StripAssay®
CF StripAssay® TUR
CF StripAssay® GER

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA Diagnose Kits, DNA-Analytik

FMF StripAssays®

Familial Mediterranean Fever (FMF) is characterized by recurrent episodes of fever accompanied by painful inflammatory events.
The FMF StripAssays® identify the most frequent mutations in the MEFV gene and risk factors for Amyloidosis.

FMF StripAssay®
FMF-SAA1 StripAssay®

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA Diagnose Kits, DNA-Analytik

Gaucher Disease StripAssay®

Gaucher Disease, the most common inherited lysosomal storage disorder, is caused by glucocerebrosidase deficiency due to mutations in the GBA gene.

The Gaucher Disease StripAssay® identifies the most frequent mutations and recombinant alleles.

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA Diagnose Kits, DNA-Analytik

Haemochromatosis Assays

Hereditary haemochromatosis is one of the most common genetic disorders. It is characterized by progressive accumulation of iron in various organs.
ViennaLab assays identify the most common mutations causing iron overload.

Haemochromatosis StripAssay® B
Haemochromatosis StripAssay® A
HFE C282Y RealFast™ Assay
HFE H63D RealFast™ Assay

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA Diagnose Kits, DNA-Analytik

Sugar Intolerance StripAssay®

Many people do not have the necessary enzymes in sufficient quantities to digest lactose and fructose.
ViennaLab assays identify the most frequent genetic variations responsible for sugar intolerance.

Lactose Intolerance StripAssay®
Sugar Intolerance StripAssay®
LCT-13910C>T RealFast™ Assay

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA Diagnose Kits, DNA-Analytik

Thalassemia StripAssays®

α-and β-thalassemia are severe forms of anemia caused by specific mutations in the globin genes of the haemoglobin molecule.
Globin StripAssays®, optimized for regional prevalences, identify the most relevant mutations.

ß-Globin StripAssay® MED
ß-Globin StripAssay® IME
ß-Globin StripAssay® SEA
α-Globin StripAssay®
ß-Thal Modifier StripAssay®

Mehr Weniger

Produktkategorie: Gentests / Molekularbiologische Diagnostik, DNA-Analytik, Diagnostika / Kits für die Pharmaka-Bestimmung

PGX-Thrombo StripAssay®

Oral anticoagulants like coumarin are commonly used to prevent and treat stroke. Genetic variants influence drug efficacy potentially leading to life-threatening wrong dosage.

The PGX-Thrombo StripAssay® identifies the most relevant genetic variations influencing coumarin anticoagulation therapy.

Mehr Weniger

Produktkategorie: DNA-Analytik, DNA Diagnose Kits, Gentests / Molekularbiologische Diagnostik

Apo-E StripAssay®

Specific Apolipoprotein E variants can cause Alzheimer's Disease or Cardiovascular Disease.
The ApoE StripAssay® easily identifies the E2, E3 and E4 variants of ApoE.

Mehr Weniger

Produktkategorie: DNA-Analytik, DNA Diagnose Kits, Gentests / Molekularbiologische Diagnostik

CVD Assays

Cardiovascular Diseases (CVD) are often caused by a combination of a genetic predisposition and an unhealthy lifestyle.
CVD StripAssays® and RealFast™ Assays identify various combinations of genetic CVD risk factors.

FV-PTH-MTHFR StripAssay®
Apo-E StripAssay®
FV-PTH StripAssay®
FV StripAssay®
PTH StripAssay®
MTHFR StripAssay®
CVD StripAssay® T
CVD StripAssay® A
FV Leiden RealFast™ Assay
PTH 20210G>A RealFast™ Assay
MTHFR 677C>T RealFast™ Assay
MTHFR 1298A>C RealFast™ Assay
PAI-1 4G/5G RealFast™ Assay

Mehr Weniger

Produktkategorie: DNA-Analytik, DNA Diagnose Kits, Gentests / Molekularbiologische Diagnostik, Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

HLA Assays

HLA-B27 is a genetic risk factor for seronegative spondyloarthropathies, such as ankylosing spondylitis, reactive arthritis, juvenile rheumatoid arthritis
and anterior uveitis.
ViennaLab HLA-B27 assays detect all disease-relevant HLA-B27 subtypes.

HLA-B27 StripAssay®
HLA-B27 RealFast™ Assay

HLA-B5701 is a genetic risk factor for hypersensitivity reactions to abacavir, an antiretroviral drug used in HIV therapy.
The HLA-B5701 RealFast™ Assay discriminates the presence or absence of HLA-B5701 in HIV-infected patients.

Mehr Weniger

Produktkategorie: DNA-Analytik

StripAssay® Evaluator

For scanning and analyzing teststrips that have been processed according to StripAssay® instructions.
In combination with a flatbed office scanner the Evaluator software permits one-step, automated analysis of up to 20 teststrips.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Tumormarker-Bestimmung, Diagnostika / Kits für die Pharmaka-Bestimmung, Tumormarker

PGX-5FU StripAssay®: Response to Fluorouracil Therapy

The majority of the 3 to 5% of patients not adequately metabolizing 5-fluorouracil (5-FU) carry a specific mutation in their DPYD gene.
While heterozygous patients should be given lower 5-FU doses, homozygous patients should receive alternative chemotherapeutic treatment.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung, Tumormarker, Diagnostika / Kits für die Tumormarker-Bestimmung

PGX-TPMT StripAssay®: Response to Thiopurine-based Therapy

Thiopurines are widely used in the treatment of leukemias and autoimmune disorders, such as Crohn’s disease and rheumatoid arthritis.
Their use as immunosuppressants after organ transplantation is equally well established. Thiopurine-based drugs are metabolized by the enzyme thiopurine S-methyltransferase (TPMT). Impaired TPMT enzyme activity results in an accumulation of thiopurines and toxic effects on the bone marrow (myelosuppression).

The PGX-TPMT StripAssay® identifies the most frequent polymorphisms in the TPMT gene with therapeutic relevance.

Mehr Weniger

Produktkategorie: Tumormarker, Diagnostika / Kits für die Tumormarker-Bestimmung

FCGR StripAssay®

Germline polymorphisms in the Fc gamma receptor (FCGR) have been reported to impact antibody-based cancer therapies.

The FCGR StripAssay® identifies the variants FCGR2A H131R and FCGR3A F158V.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

PGX-CYP2C19 StripAssay®

Variations in the CYP2C19 gene lead to inappropriate concentrations of drugs or drug metabolites in the body, which may lead to toxicity, risk of adverse drug reactions or impaired drug efficacy.

The PGX-CYP2C19 StripAssay® detects genetic variants resulting in reduced or increased activity of the cytochrome P450 isoenzyme CYP2C19.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

PGX-CYP2D6 StripAssay®

Differences in the activity of the liver enzyme CYP2D6 contribute to the inter-individual variability in drug response.

The PGX-CYP2D6 StripAssay® detects the most common variants with impaired enzyme activity.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

PGX-HIV StripAssay®

Highly active retroviral therapy (HAART) is a very effective treatment for HIV-positive patients. Allelic variants of certain proteins are known to be associated with success of HAART.

The PGX-HIV StripAssay® identifies mutations in genes known to be relevant for the success of HAART.

Mehr Weniger

Produktkategorie: Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

MTHFR Assays

Mutations in the methylenetetrahydrofolate reductase (MTHFR) gene are associated with decreased enzyme activity, which leads to hyperhomocysteinemia and toxic side effects of methotrexate therapy.

ViennaLab assays identify patients predisposed to develop cardiovascular diseases or intolerance to methotrexate.

MTHFR StripAssay®
MTHFR 677C>T RealFast™ Assay
MTHFR 1298A>C RealFast™ Assay

Mehr Weniger

Produktkategorie: Tumormarker, Diagnostika / Kits für die Tumormarker-Bestimmung, Therapeutische Medikamentenüberwachung, Diagnostika / Kits für die Pharmaka-Bestimmung

KRAS & NRAS StripAssays®

Monoclonal antibody therapies targeting EGFR work exceptionally well in metastatic colorectal cancer. However, certain mutations in the KRAS and NRAS genes prevent success of these therapies.

The KRAS and NRAS StripAssays® rapidly identify the most relevant mutations in the KRAS and NRAS genes.

Mehr Weniger

Produktkategorie: Tumormarker, Diagnostika / Kits für die Tumormarker-Bestimmung, Diagnostika / Kits für die Pharmaka-Bestimmung

BRAF StripAssays®

The BRAF gene is mutated in approximately 8% of human tumors, mostly melanoma, colorectal and thyroid cancers.
The BRAF StripAssays® rapidly identify the most relevant mutations in the BRAF gene.

BRAF 600/601 StripAssay®
BRAF StripAssay®
KRAS-BRAF StripAssay®

Mehr Weniger

Produktkategorie: Tumormarker, Diagnostika / Kits für die Tumormarker-Bestimmung

EGFR StripAssay®

Non-small cell lung cancers (NSCLC) comprise approximately 85% of all lung cancers. Somatic mutations in the epidermal growth factor receptor tyrosine kinase (EGFR-TK) domain influence the treatment with EGFR-TK inhibitors.

The EGFR StripAssay® identifies the most important mutations relevant for anti EGFR-TK therapy.

Mehr Weniger

Über uns

Firmenporträt

Bitte besuchen Sie unsere Website, um mehr über unser Unternehmen zu erfahren. Wir freuen uns auf Ihren Besuch an unserem Stand auf der MEDICA 2015!

Mehr Weniger

Unternehmensdaten

Exportanteil

> 75%

Anzahl der Beschäftigten

1-19

Gründungsjahr

1990

Geschäftsfelder

Diagnostika